Table 3.
Association between maspin expression and clinicopathological factors in triple-negative breast cancer
| Maspin expression | |||
|---|---|---|---|
| Positive (85.9%) 116 cases | Negative (14.1%) 19 cases | P-value | |
| Age (years) | |||
| ≤50 | 50 | 1 | 0.0015 |
| >50 | 66 | 18 | |
| Tumor size (mm) | |||
| ≤20 | 41 | 3 | 0.091 |
| >20 | 75 | 16 | |
| Lymph node metastases | |||
| 0 | 69 | 13 | 0.226 |
| 1-3 | 27 | 1 | |
| 3< | 20 | 4 | |
| Histological grade | |||
| I | 4 | 1 | 0.0013 |
| II | 19 | 10 | |
| III | 93 | 8 | |
| EGFR | |||
| Positive | 57 | 9 | 0.886 |
| Negative | 59 | 10 | |
| CK5/6 | |||
| Positive | 77 | 3 | <0.0001 |
| Negative | 39 | 16 | |
| CK14 | |||
| Positive | 45 | 1 | 0.0034 |
| Negative | 71 | 18 | |
| CD10 | |||
| Positive | 19 | 5 | 0.293 |
| Negative | 97 | 14 | |
| p63 | |||
| Positive | 15 | 2 | 0.769 |
| Negative | 101 | 17 | |